These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 25065513

  • 1. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
    Kruse RL, Kramer JR, Tyson GL, Duan Z, Chen L, El-Serag HB, Kanwal F.
    Hepatology; 2014 Dec; 60(6):1871-8. PubMed ID: 25065513
    [Abstract] [Full Text] [Related]

  • 2. Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.
    El-Serag HB, Kramer J, Duan Z, Kanwal F.
    Am J Gastroenterol; 2014 Sep; 109(9):1427-35. PubMed ID: 25070058
    [Abstract] [Full Text] [Related]

  • 3. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS, Tovo CV, Kliemann DA, Fisch P, de Mattos AA.
    World J Gastroenterol; 2018 Feb 07; 24(5):613-622. PubMed ID: 29434450
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.
    Yang WT, Wu LW, Tseng TC, Chen CL, Yang HC, Su TH, Wang CC, Kuo SF, Liu CH, Chen PJ, Chen DS, Liu CJ, Kao JH.
    Medicine (Baltimore); 2016 Mar 07; 95(10):e2995. PubMed ID: 26962809
    [Abstract] [Full Text] [Related]

  • 5. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
    Oh JK, Shin HR, Lim MK, Cho H, Kim DI, Jee Y, Yun H, Yoo KY.
    BMC Cancer; 2012 Oct 05; 12():452. PubMed ID: 23039099
    [Abstract] [Full Text] [Related]

  • 6. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.
    Giordano TP, Kramer JR, Souchek J, Richardson P, El-Serag HB.
    Arch Intern Med; 2004 Nov 22; 164(21):2349-54. PubMed ID: 15557414
    [Abstract] [Full Text] [Related]

  • 7. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R.
    Cancer; 1999 May 15; 85(10):2132-7. PubMed ID: 10326690
    [Abstract] [Full Text] [Related]

  • 8. The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection.
    Kramer JR, Kowalkowski MA, Duan Z, Chiao EY.
    J Acquir Immune Defic Syndr; 2015 Apr 01; 68(4):456-62. PubMed ID: 25559606
    [Abstract] [Full Text] [Related]

  • 9. Mediation effect of hepatitis B and C on mortality.
    Huang YT, Freeman JR, Yang HI, Liu J, Lee MH, Chen CJ.
    Eur J Epidemiol; 2016 Jun 01; 31(6):625-33. PubMed ID: 26792787
    [Abstract] [Full Text] [Related]

  • 10. The negative impact of HBV/HCV coinfection on cirrhosis and its consequences.
    Pol S, Haour G, Fontaine H, Dorival C, Petrov-Sanchez V, Bourliere M, Capeau J, Carrieri P, Larrey D, Larsen C, Marcellin P, Pawlostky JM, Nahon P, Zoulim F, Cacoub P, de Ledinghen V, Mathurin P, Negro F, Pageaux GP, Yazdanpanah Y, Wittkop L, Zarski JP, Carrat F, French Anrs Co22 Hepather Cohort.
    Aliment Pharmacol Ther; 2017 Dec 01; 46(11-12):1054-1060. PubMed ID: 28994127
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
    Tyson GL, Kramer JR, Duan Z, Davila JA, Richardson PA, El-Serag HB.
    Hepatology; 2013 Aug 01; 58(2):538-45. PubMed ID: 23505059
    [Abstract] [Full Text] [Related]

  • 12. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E, European Concerted Action on Viral Hepatitis (EUROHEP).
    Am J Gastroenterol; 2002 Nov 01; 97(11):2886-95. PubMed ID: 12425564
    [Abstract] [Full Text] [Related]

  • 13. Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis.
    Cho LY, Yang JJ, Ko KP, Park B, Shin A, Lim MK, Oh JK, Park S, Kim YJ, Shin HR, Yoo KY, Park SK.
    Int J Cancer; 2011 Jan 01; 128(1):176-84. PubMed ID: 20232388
    [Abstract] [Full Text] [Related]

  • 14. The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection.
    Ioannou GN, Bryson CL, Weiss NS, Miller R, Scott JD, Boyko EJ.
    Hepatology; 2013 Jan 01; 57(1):249-57. PubMed ID: 22532055
    [Abstract] [Full Text] [Related]

  • 15. HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV.
    Kanwal F, Kramer JR, Ilyas J, Duan Z, El-Serag HB.
    Hepatology; 2014 Jul 01; 60(1):98-105. PubMed ID: 24615981
    [Abstract] [Full Text] [Related]

  • 16. Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort.
    Quaranta MG, Ferrigno L, Monti M, Filomia R, Biliotti E, Iannone A, Migliorino G, Coco B, Morisco F, Vinci M, D'Ambrosio R, Chemello L, Massari M, Ieluzzi D, Russo FP, Blanc P, Verucchi G, Puoti M, Rumi MG, Barbaro F, Santantonio TA, Federico A, Chessa L, Gentile I, Zuin M, Parruti G, Morsica G, Kondili LA, PITER Collaborating Group.
    Hepatol Int; 2020 May 01; 14(3):362-372. PubMed ID: 32279177
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.